Fidelity MSCI Health Care Index ETF (FHLC) is a healthcare and biotech ETF. As of October 28, 2026, ETF Copilot scores FHLC 5.3 out of 10 — highest on Risk (8.2), lowest on Value (0.9). It trades at 32.8 times earnings, against its own median of 25.3. Its ten largest holdings are 52% of the fund.
What stands out in FHLC's data
U.S. healthcare companies, tracked through a broad index.
Trades at a richer price than most healthcare peers — you pay more for each dollar of earnings.
Its trailing P/E multiple of 32.8x is among the most expensive in the healthcare category, above the median of 29.6x. The fund charges just 0.08% annually.
A broad sector position that keeps healthcare exposure without tilting toward any one subspecialty.
Why did FHLC move this week? It rose 0.8% in the week to October 28, 2026 — Johnson & Johnson and Eli Lilly drove it
FHLC rose 0.8% in the week to October 28, 2026. The holdings that moved it most were Johnson & Johnson (+5.1%), Eli Lilly (+1.4%) and Amgen (+3.1%); Merck (−6.0%) pushed the other way.
How is FHLC rated? ETF Copilot scores Fidelity MSCI Health Care Index ETF (FHLC) 5.3 out of 10
As of October 28, 2026, ETF Copilot scores Fidelity MSCI Health Care Index ETF (FHLC) 5.3 out of 10 overall.
ETF Copilot scores (0–10 scale, higher is better):
- Overall: 5.3 / 10
- Growth: 6.2 / 10
- Value: 0.9 / 10
- Risk: 8.2 / 10
- Quality: 5.6 / 10
- Return: 5.1 / 10
Is FHLC expensive right now? It trades at 32.8 times earnings, against its own median of 25.3
As of October 28, 2026, FHLC is more expensive than 98% of its own last 9 years.
Trailing 12 months, built from FHLC's holdings. How we calculate this →
What's inside FHLC?
What's inside FHLC: Size (Large 84%, Mid 12%, Small 4%); Geography (International 3%, US 97%); AI 0.4%.
What are FHLC's top holdings? The ten largest are 52% of the fund
Eli Lilly, Johnson & Johnson, Abbvie, UnitedHealth, Merck, Thermo Fisher Scientific, Amgen, Gilead Sciences, Abbott Laboratories and Pfizer are FHLC's largest holdings, in that order.
More concentrated than 63% of Health & Biotech ETFs.
Half of FHLC's weight sits in its 10 largest positions, and once those weights are taken into account it behaves like 24 equally weighted holdings.
What is FHLC's expense ratio? 0.08% a year
As of October 28, 2026, FHLC charges 0.08% a year, yields 1.17% and holds $3.8B in assets across 326 positions.
| Measure | FHLC |
|---|---|
| Expense ratio | 0.08% |
| Dividend yield | 1.17% |
| Assets under management | $3.8B |
| Holdings | 326 |
Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.
Cite this
ETF Copilot, “Fidelity MSCI Health Care Index ETF (FHLC) scores and holdings analysis”, as of October 28, 2026.
https://etf-copilot.com/etf/fhlc
ETF Copilot Pro unlocks FHLC's price and what each holding weighs.
Try Pro free →